Pharmaceuticals & Life Sciences

We provide one-stop, high-caliber services to meet the diverse needs of clients of various types and at different development stages through our integrated service platform. We have a seasoned and influential bench consisting of dozens of partners and associates who have served years in the pharmaceuticals and life sciences sector. Powered by solid expertise and abundant experience, as well as a deep insight into the patterns and trends of this sector, our lawyers actively participate in research and formulation of public policies and innovation of transaction types and models.

As a market leader in the legal services relating to pharmaceuticals and life sciences, we never deviate from our continued efforts to increase the scope and sophistication of our services and enhance the innovation of our service models. Our work spans sub-sectors such as new drugs, bioproducts, reagents, pharmaceuticals, CRO, CDMO, medical devices, gene editing, gene sequencing and genetic diagnosis, human body data collection and monitoring, bioequivalence, distribution of drugs, health foods, cosmetics, biomedical funds and incubation platforms, medical e-commerce, health data processing, and pharmacovigilance. With a wide range of capabilities covering the entire industry chain, we provide services encompassing incorporation, financing, incentive plan, in-license, out-license and protection of intellectual property, M&A, IPO, compliant operation, anti-corruption, antitrust, dispute resolution, and other matters. Keeping abreast with the latest policies and development models of the industry, we are both down-to-earth and forward-looking in our services, which helps us maintain a widely respected profile in the market.

Scope of Services

Dispute Resolution

  • Representing pharmaceuticals and life sciences clients in disputes over contracts, distributorship agreements, clinical trials of drugs, medical liability, and monopoly and unfair competition, among others

Compliance Investigations

  • Representing businesses in the pharmaceuticals and life sciences sector in responding to criminal and administrative law enforcement actions by competent authorities; cooperating with overseas lawyers in responding to anti-corruption and anti-bribery investigations conducted by overseas regulators; and conducting internal investigations of anti-commercial bribery, compliance reviews on business partners, and other compliance investigations for clients

Intellectual Property

  • Providing clients with cross-regional, comprehensive, professional, and innovative services offered by our specialist teams working at offices in global metropolises such as Beijing, Shanghai, Guangzhou, Hong Kong, London, and New York. Our services cover cross-border M&A, new drug launch, drug R&D, patent portfolio, transfer, cooperation, development, and licensing of technology, and intellectual property related dispute resolution

Administration and Regulation of Medical Products

  • Advising on administration and regulation of pharmaceuticals and medical devices, including compliance of product R&D and clinical trials; product registration, manufacturing, distribution, packaging, and marketing; adverse drug events and product recall; tender; antitrust and price control

Governance and Compliance

  • Designing frameworks of and reviewing internal rules for pharmaceuticals and life sciences businesses regarding drug R&D and trials, product sale and marketing, third-party management, and other matters; providing review comments on compliance of internal rules, with our services covering the whole operating process of pharmaceutical businesses, including industry access and regulation, academic activities, interaction between pharmaceutical businesses and healthcare service providers, digital marketing, online sale of drugs, medical e-commerce, pharmacovigilance, and health data processing; and providing compliance training to the management, employees, and business partners in the pharmaceuticals and life sciences sector

Domestic and Overseas Capital Markets

  • Pre-IPO ownership reform and restructuring, pre-IPO PE financing, corporate governance of listed companies, daily capital market legal services for listed companies, Chinese and overseas IPOs and listings, acquisition of listed companies, backdoor listings, refinancing of listed companies, and major asset restructuring of listed companies

Investment, Financing, M&A, and Restructuring

  • Investment in shares, equities, or interests in, and financing and M&As of corporate and non-corporate entities in the pharmaceuticals and life sciences sector; establishment, fundraising, liquidation, dissolution, and daily management of PE funds or VC funds investing in this sector, as well as investment by and M&As and exit of these funds; and ownership reform and restructuring of state-owned enterprises, public institutions, and non-profit organizations, and conversion of them into businesses


  • Latest
  • Most relevant